2025 · 4th Quarter (Oct 1 - Dec 31)

ELEKTA, INC.

Filed by ELEKTA, INC..

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jun 30, 2026
Income: Not reported
Expenses: $70,000.00
Registrant: ELEKTA, INC.
Client: ELEKTA, INC.
Filing UUID: f1367d98-f2f8-45f2-a684-356f04cd8a07
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

HHS, Labor and Education Appropriations Energy Appropriations

ENG · Energy/Nuclear

Gamma Knife/Cobalt-60 Nuclear Material for Medical Use Radioactive Material for Medical Use

HCR · Health Issues

Radiation Oncology/ Radiation Therapy Cancer Care General Oncology issues Healthcare reimbursement

MED · Medical/Disease Research/Clinical Labs

Radiation Oncology Cancer Care

MMM · Medicare/Medicaid

ROCR legislation H.R. 1031 and S. 2021 Medicare access Medicare reimbursement General Medicare issues Medicaid access Medicaid reimbursement General Medicaid issues

Literal federal measure citations: H.R. 1031, S. 2021

TAR · Tariff (miscellaneous tariff bills)

General Tariff issues USMCA US-EU trade agreement US-UK trade agreement

TRD · Trade (domestic/foreign)

General Trade issues USMCA US-EU trade deal US-UK trade deal

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.